Venture Visionary Partners LLC Merck & Co., Inc. Transaction History

Venture Visionary Partners LLC

$2.25 Billion
Q3 2024

A detailed history of Venture Visionary Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Venture Visionary Partners LLC holds 53,180 shares of MRK stock, worth $5.21 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

53,180

Previous 55,590 4.34%

Holding current value

$5.21 Million

Previous $6.88 Million 12.25%

% of portfolio

0.27%

Previous 0.32%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$111.15 - $128.97 $267,871 - $310,817	-2,410 Reduced 4.34%	53,180 $6.04 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $170,596 - $183,218	1,378 Added 2.54%	55,590 $6.88 Million
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $214,250 - $249,649	1,892 Added 3.62%	54,212 $7.15 Million
Q4 2023 Feb 15, 2024	SELL	$100.18 - $109.02 $137,446 - $149,575	-1,372 Reduced 2.56%	52,320 $5.7 Million
Q4 2023 Jan 24, 2024	SELL	$100.18 - $109.02 $88,258 - $96,046	-881 Reduced 1.61%	53,692 $5.85 Million
Q3 2023 Oct 13, 2023	BUY	$102.95 - $114.33 $48,077 - $53,392	467 Added 0.86%	54,573 $5.62 Million
Q2 2023 Jul 14, 2023	BUY	$108.61 - $118.38 $543 - $591	5 Added 0.01%	54,106 $6.24 Million
Q1 2023 Apr 13, 2023	SELL	$102.94 - $114.86 $843,078 - $940,703	-8,190 Reduced 13.15%	54,101 $5.76 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $31,915 - $40,920	-365 Reduced 0.58%	62,291 $6.91 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $293,319 - $329,511	-3,470 Reduced 5.25%	62,656 $5.4 Million
Q2 2022 Jul 26, 2022	SELL	$83.49 - $94.64 $65,289 - $74,008	-782 Reduced 1.17%	66,126 $6.03 Million
Q1 2022 May 03, 2022	SELL	$73.51 - $82.4 $96,445 - $108,108	-1,312 Reduced 1.92%	66,908 $5.49 Million
Q4 2021 Feb 08, 2022	SELL	$72.28 - $90.54 $141,668 - $177,458	-1,960 Reduced 2.79%	68,220 $5.17 Million
Q3 2021 Oct 20, 2021	BUY	$71.68 - $78.83 $356,679 - $392,258	4,976 Added 7.63%	70,180 $5.27 Million
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $192,719 - $213,167	-2,741 Reduced 4.03%	65,204 $5.07 Million
Q1 2021 Apr 27, 2021	BUY	$68.86 - $81.11 $1.57 Million - $1.85 Million	22,806 Added 50.52%	67,945 $5.24 Million
Q4 2020 Jan 27, 2021	BUY	$71.77 - $79.65 $2.7 Million - $3 Million	37,640 Added 501.93%	45,139 $3.69 Million
Q3 2020 Oct 22, 2020	BUY	$73.18 - $82.95 $89,352 - $101,281	1,221 Added 19.45%	7,499 $622,000
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $7,042 - $8,013	100 Added 1.62%	6,278 $485,000
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $16,600 - $23,008	262 Added 4.43%	6,178 $475,000
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $458,963 - $517,886	5,916 New	5,916 $538,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.

Account

Venture Visionary Partners LLC Merck & Co., Inc. Transaction History